David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Investors looking at energy stocks may have a bit of whiplash these days. Oil prices appear fairly firm while natural gas prices still remain near multi-year lows. In other countries, natural gas prices are surging, as demand rises in places that have de-commissioned nuclear power plants, such as Japan and… Read More
Back in January, I highlighted that state and local governments were starting to turn to legalizing gambling to shore up their tax bases. Since then, the activity has only increased. Massachusetts recently held a forum to hear arguments on why it should develop casinos, and Maryland set up a… Read More
To many people, it’s hard to justify investing in companies that make such unloved products as tobacco, weapons or even alcohol. But income investors can find lots of reasons to like tobacco and alcohol stocks, namely their defensive nature and the fact that they typically perform quite well. Read More
It’s so important to learn from the nation’s top investors. You don’t need to tell that to the thousands that flock to Omaha, Nebraska once a year to glean fresh wisdom from Warren Buffett. Many others follow the actions of George Soros, Carl Icahn or others. These top investors have… Read More
My husband Melvin and I bought our first home when we were expecting our first child. After an exhaustive search, we settled on an up-and-down duplex. It was built in the 1940s and had a rental suite in the basement. The purchase was a good decision from… Read More
With all due respect to famed economist Burton Malkiel, but stocks don’t make a “random walk.” His famous book from 1973, A Random Walk Down Wall Street, opined that the stock market incorporates all information and there is… Read More
It might be the most controversial statement I’ve ever told investors… In fact, you’re likely to shrug me off at first, as what I’m about to tell you goes against everything you’ve been taught about wealth management. Read More
In this low interest rate environment, investors have turned to high-yielding blue-chips as a source of retirement income. This five-part series will outline what I believe to be the top five dividend aristocrat stocks, most suitable for a retiree’s portfolio. In my previous articles on… Read More
Low prices for this commodity are leading to new and innovative ways to use it. Read More
What on Earth is Steven A. Cohen thinking? He’s authorized traders at his investment firm, SAC Capital, to quickly build a large position in Accretive Health (NYSE: AH). Roughly a week ago, SAC announced that it had already bought so many shares that it… Read More
